Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice

Journal of Virology

Volumn 83, Issue 21, 2009, Pages 10981-10992

  Jin, Young Hee ^a   Kang, Bongsu ^a   Kim, Byung S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PEPTIDE LIBRARY; RNA POLYMERASE; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FEMALE; IMMUNIZATION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PICORNAVIRUS INFECTION; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENOME;

ANIMALS; CARDIOVIRUS INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DEMYELINATING DISEASES; DNA-DIRECTED RNA POLYMERASES; EPITOPES; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PEPTIDES; SPLEEN; THEILOVIRUS; VIRAL PROTEINS;

MIRIDAE; MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 70350289945     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01398-09     Document Type: Article

References (51)

1. Allen, I., and B. Brankin. 1993. Pathogenesis of multiple sclerosis: the immune diathesis and the role of viruses. J. Neuropathol. Exp. Neurol. 52:95-105.
2. Begolka, W. S., L. M. Haynes, J. K. Olson, J. Padilla, K. L. Neville, M. Dal Canto, J. Palma, B. S. Kim, and S. D. Miller. 2001. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. J. Neurovirol. 7:409-420.
3. b molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J. Virol. 71:5244-5250.
4. Bureau, J. F., X. Montagutelli, F. Bihl, S. Lefebvre, J. L. Guenet, and M. Brahic. 1993. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat. Genet. 5:87-91.
5. Cedillo-Barron, L., M. Foster-Cuevas, A. Cook, B. Gutierrez-Castaneda, S. Kollnberger, F. Lefevre, and R. M. Parkhouse. 2003. Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 21:4261-4269. (Pubitemid 37138696)
6. Chiu, C. Y., A. L. Greninger, K. Kanada, T. Kwok, K. F. Fischer, C. Runckel, J. K. Louie, C. A. Glaser, S. Yagi, D. P. Schnurr, T. D. Haggerty, J. Parsonnet, D. Ganem, and J. L. DeRisi. 2008. Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc. Natl. Acad. Sci. USA 105:14124-14129.
7. Dethlefs, S., N. Escriou, M. Brahic, S. van der Werf, and E. L. Larsson-Sciard. 1997. Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J. Virol. 71:5361-5365. (Pubitemid 27258211)
8. Dhib-Jalbut, S., and D. E. McFarlin. 1990. Immunology of multiple sclerosis. Ann. Allergy. 64:433-444.
9. Fiette, L., C. Aubert, M. Brahic, and C. P. Rossi. 1993. Theiler's virus infection of β2-microglobulin-deficient mice. J. Virol. 67:589-592. (Pubitemid 23003027)
10. Garcia-Briones, M. M., E. Blanco, C. Chiva, D. Andreu, V. Ley, and F. Sobrino. 2004. Immunogenicity and T-cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology 322:264-275. (Pubitemid 38521141)
11. Gerety, S. J., W. J. Karpus, A. R. Cubbon, R. G. Goswami, M. K. Rundell, J. D. Peterson, and S. D. Miller. 1994. Class II-restricted T-cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T-cell epitope in susceptible SJL/J. mice. J. Immunol. 152:908-918.
12. + cytotoxic T cells. J. Virol. 81:6584-6593.
13. Hou, W., H. S. Kang, and B. S. Kim. 2009. Th17 cells enhance viral persistence and inhibit T-cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206:313-328.
14. Hou, W., E. Y. So, and B. S. Kim. 2007. Role of dendritic cells in differential susceptibility to viral demyelinating disease. PLoS Pathog. 3:e124. (Pubitemid 47359082)
15. Jang, Y. S., J. A. Mikszta, and B. S. Kim. 1994. T-cell epitope recognition involved in the low-responsiveness to a region of hen egg lysozyme (46-61) in C57BL/6 mice. Mol. Immunol. 31:803-812.
16. Jin, Y. H., M. Mohindru, M. H. Kang, A. C. Fuller, B. Kang, D. Gallo, and B. S. Kim. 2007. Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus. J. Virol. 81:11690-11702.
17. + T cells in the central nervous system of susceptible SJL/J. mice infected with Theiler's virus are virus specific and fully functional. J. Virol. 76:6577-6585.
18. Karpus, W. J., N. W. Lukacs, B. L. McRae, R. M. Strieter, S. L. Kunkel, and S. D. Miller. 1995. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:5003-5010.
19. + Th1 but not Th2 cytokine responses. Int. Immunol. 6:721-730.
20. Karpus, W. J., J. G. Pope, J. D. Peterson, M. C. Dal Canto, and S. D. Miller. 1995. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155:947-957.
21. Kedzierska, K., E. B. Day, J. Pi, S. B. Heard, P. C. Doherty, S. J. Turner, and S. Perlman. 2006. Quantification of repertoire diversity of influenza-specific epitopes with predominant public or private TCR usage. J. Immunol. 177:6705-6712. (Pubitemid 44715034)
22. Kim, B. S., J. P. Palma, A. Inoue, and C. S. Koh. 2000. Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis. Arch. Immunol. Ther. Exp. 48:373-379.
23. Kim, B. S., R. L. Yauch, Y. Y. Bahk, J. A. Kang, M. C. Dal Canto, and C. K. Hall. 1998. A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope. J. Virol. 72:1020-1027.
24. Liang, Z., A. S. Kumar, M. S. Jones, N. J. Knowles, and H. L. Lipton. 2008. Phylogenetic analysis of the species theilovirus: emerging murine and human pathogens. J. Virol. 82:11545-11554.
25. Lipton, H. L., and M. C. Dal Canto. 1976. Chronic neurologic disease in Theiler's virus infection of SJL/J. mice. J. Neurol. Sci. 30:201-207.
26. Lipton, H. L., J. Kratochvil, P. Sethi, and M. C. Dal Canto. 1984. Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology 34:1117-1119.
27. Lipton, H. L., and R. Melvold. 1984. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132:1821-1825.
28. b-restricted regions of the BeAn strain of Theiler's virus and exhibit different cytokine profiles. J. Virol. 76:3125-3134.
29. + T-cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J. mice. Eur. J. Immunol. 34:2730-2739.
30. Mikszta, J. A., Y. S. Jang, and B. S. Kim. 1997. Role of a C-terminal residue of an immunodominant epitope in T-cell activation and repertoire diversity. J. Immunol. 158:127-135.
31. + T-cell responses protect against Theiler's murine encephalomyelitisvirus-induced demyelinating disease. Eur. J. Immunol. 36:2106-2115.
32. Murray, P. D., D. B. McGavern, X. Lin, M. K. Njenga, J. Leibowitz, L. R. Pease, and M. Rodriguez. 1998. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18:7306-7314.
33. Palma, J. P., and B. S. Kim. 2001. Induction of selected chemokines in glial cells infected with Theiler's virus. J. Neuroimmunol. 117:166-170.
34. Palma, J. P., H. G. Lee, M. Mohindru, B. S. Kang, M. Dal Canto, S. D. Miller, and B. S. Kim. 2001. Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice. J. Neuroimmunol. 116:125-135. (Pubitemid 32588625)
35. Palma, J. P., R. L. Yauch, H. K. Kang, H. G. Lee, and B. S. Kim. 2002. Preferential induction of IL-10 in APC correlates with a switch from Th1 to Th2 response following infection with a low pathogenic variant of Theiler's virus. J. Immunol. 168:4221-4230.
36. Peterson, J. D., W. J. Karpus, R. J. Clatch, and S. D. Miller. 1993. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. Eur. J. Immunol. 23:46-55.
37. Pullen, L. C., S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1993. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T-cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 23:2287-2293.
38. Pullen, L. C., S. H. Park, S. D. Miller, M. C. Dal Canto, and B. S. Kim. 1995. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J. Immunol. 155:4497-4503.
39. Rivera-Quinones, C., D. McGavern, J. D. Schmelzer, S. F. Hunter, P. A. Low, and M. Rodriguez. 1998. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4:187-193.
40. Rodriguez, M., and C. S. David. 1985. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135:2145-2148. (Pubitemid 16240050)
41. Rodriguez, M., A. J. Dunkel, R. L. Thiemann, J. Leibowitz, M. Zijlstra, and R. Jaenisch. 1993. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in β2-microglobulin. J. Immunol. 151:266-276. (Pubitemid 23206991)
42. Rodriguez, M., J. L. Leibowitz, and P. W. Lampert. 1983. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:426-433.
43. Rossi, C. P., A. McAllister, M. Tanguy, D. Kagi, and M. Brahic. 1998. Theiler's virus infection of perforin-deficient mice. J. Virol. 72:4515-4519. (Pubitemid 28188767)
44. Soldan, S. S., R. Berti, N. Salem, P. Secchiero, L. Flamand, P. A. Calabresi, M. B. Brennan, H. W. Maloni, H. F. McFarland, H. C. Lin, M. Patnaik, and S. Jacobson. 1997. Association of human herpesvirus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3:1394-1397.
45. Targoni, O. S., and P. V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T-cell repertoire. J. Exp. Med. 187:2055-2063.
46. Usherwood, E. J., I. C. Johnston, L. J. Lovelidge, P. Tonks, and A. A. Nash. 1995. Lymphocyte recognition elements on the VP1 protein of Theiler's virus. Immunology 85:190-197.
47. +-T cell site on the nucleocapsid protein contributes to protection. Adv. Exp. Med. Biol. 342:413-418.
48. Yauch, R. L., K. Kerekes, K. Saujani, and B. S. Kim. 1995. Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J. mice. J. Virol. 69:7315-7318.
49. Yauch, R. L., and B. S. Kim. 1994. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J. mice infected with Theiler's virus is located within VP1(233-244). J. Immunol. 153:4508-4519.
50. Yauch, R. L., J. P. Palma, H. Yahikozawa, C. S. Koh, and B. S. Kim. 1998. Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J. Virol. 72:6169-6174.
51. Zheng, L., M. A. Calenoff, and M. C. Dal Canto. 2001. Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J. Neuroimmunol. 118:256-267. (Pubitemid 32728359)